Navigation Links
UChicago Celiac Disease Center to host international symposium

The University of Chicago Celiac Disease Center is hosting the 15th International Celiac Disease Symposium (ICDS) on Sept. 22-25, 2013 in Chicago. The symposium is the largest celiac disease and gluten-related disorders conference in the world. The meeting, which follows the 2011 conference in Oslo, Norway, is the first one being held in the United States since 2006.

The Chicago meeting seeks to address the interests of those affected by celiac disease and gluten-related disorders from physicians, researchers and clinicians to patients, their families and friends. The meeting will bring together the world's top scientists and physicians to discuss the most recent scientific advances in managing and treating celiac disease and gluten-related disorders, while a separate clinical forum will be held to further educate dietitians, clinicians, and patients.

"We are thrilled to be hosting this unique and important gathering and expect groundbreaking research to be unveiled that will directly impact the prevention of and perhaps cure of celiac disease," said Dr. Stefano Guandalini, co-chairman of ICDS 2013 and founder and medical director of the University of Chicago Celiac Disease Center. "The interaction between scientists, clinicians and consumers makes for a robust and interactive forum, unlike any other meeting."

ICDS Chicago will feature two educational tracks:

  • The Scientific Forum is designed for those in active research roles in the area of celiac disease and gluten-related disorders. This is a forum for these researchers and physicians to debate and discuss new theories and data on topics selected by the Scientific Committee.

  • The Clinical Forum is designed for physicians, registered dietitians, physician assistants, nurse practitioners, nurses and those living with celiac disease or non-celiac gluten sensitivity. The program will allow participants to learn about the latest research and scientific advances from leading experts. Presentations are geared for practical application in both clinical settings and everyday living. Additionally, the track will explore subjects such as public policy, psychology and the problems surrounding celiac disease in emerging countries. Sessions will allow ample time for Q&A and interactive discussion.

The registration fee for the Scientific Forum is $800 for researchers and physicians and $500 for students, residents and fellows. After July 31, 2013, rates will increase to $900 and $650, respectively. The registration fee for the Clinical Forum is $449 for dietitians, clinicians and patients and $349 for students, residents and fellows, increasing to $549 and $399 after July 31. The program is eligible for continuing medical education (CME) credits through the University of Chicago Pritzker School of Medicine.


Contact: Matt Wood
University of Chicago Medical Center

Related biology news :

1. Ben-Gurion U. and UChicago research collaboration targets water resource innovations
2. New canary seed is ideal for gluten-free diets in celiac disease
3. Pregnant women with high celiac disease antibodies are at risk for low birth weight babies
4. No clear evidence more gluten in new wheat is responsible for increase in celiac disease
5. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
6. Unexpected discovery of the ways cells move could boost understanding of complex diseases
7. La Jolla Institute discovers new player critical to unleashing T cells against disease
8. Artificial sweetener a potential treatment for Parkinsons disease
9. From autism to diabetes to Parkinsons disease
10. Females fend off gut diseases
11. Lifespan-extending drug given late in life reverses age-related heart disease in mice
Post Your Comments:
(Date:11/17/2015)... Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and ... of broadly enabling, pressure cycling technology ("PCT")-based sample preparation ... it has received gross proceeds of $745,000 from an ... "Offering"), increasing the total amount raised to date in ... are expected in the near future. ...
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... 2 nouvelles études permettent d ... différences entre les souches bactériennes retrouvées dans la plaque ... humains . Ces recherches  ouvrent une nouvelle ... charge efficace de l,un des problèmes de santé ... .    --> 2 nouvelles études permettent d ...
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
Breaking Biology Technology: